SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVAS-an interesting california-based biotech company here
CVAS 0.0004000.0%Oct 7 9:32 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: michael_f_murphy who wrote (110)2/25/2003 10:52:18 PM
From: Miljenko Zuanic  Read Replies (1) of 126
 
IF Provenge work in HRPC than this merge does make sense. On the other hand, CVAS may continue with single shot (rNAPc2), in all or nothing approach. I am for first one. rNAPc2 is not lost, and if it work in PII partner will be found.

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext